Sectors
DLB
Dolby Laboratories, Inc.
61.56
200 x 61.22
300 x 61.98
bid
ask
+
0.06
0.10%
250 @ 07:50 PM
61.56 +0.00 (0.00%)
| Ytd | -4.14% | |
| 1y | -14.12% |
60.14
day range
62.30
48.26
52 week range
73.78
| Open | 61.33 | Prev Close | 61.50 | Low | 60.14 | High | 62.30 | Mkt Cap | 5.77B |
| Vol | 1.03M | Avg Vol | 939.61K | EPS | 2.35 | P/E | 26.20 | Forward P/E | 13.38 |
| Beta | 0.80 | Short Ratio | 6.32 | Inst. Own | 106.59% | Dividend | 1.44 | Div Yield | 2.34 |
| Ex Div Date | 08-11 | Earning | 11-17 | 50-d Avg | 55.70 | 200-d Avg | 60.51 | 1yr Est | 79.00 |
| Income Statement | |||
| Total Revenue | 305.00M | ||
| Revenues (USD) | 305.00M | ||
| Cost of Revenue | 40.32M | ||
| Gross Profit | 264.68M | ||
| Operating Expenses | 230.36M | ||
| Research and Development Expense | 65.75M | ||
| Selling, General and Administrative Expense | 160.66M | ||
| Operating Income | 34.32M | ||
| Interest Expense | -3.45M | ||
| Income Tax Expense | 14.59M | ||
| Net Income | 28.60M | ||
| Net Income Common Stock | 28.60M | ||
| Net Income Common Stock (USD) | 28.60M | ||
| Consolidated Income | 29.21M | ||
| Net Income to Non-Controlling Interests | 612.00K | ||
| Earnings per Basic Share | 0.30 | ||
| Earnings per Basic Share (USD) | 0.30 | ||
| Earnings per Diluted Share | 0.30 | ||
| Dividends per Basic Common Share | 0.36 | ||
| Earning Before Interest & Taxes (EBIT) | 39.74M | ||
| Earning Before Interest & Taxes (USD) | 39.74M | ||
| Weighted Average Shares | 94.24M | ||
| Weighted Average Shares Diluted | 94.52M | ||
| Balance Sheet | |||
| Cash and Equivalents | 738.89M | ||
| Cash and Equivalents (USD) | 738.89M | ||
| Investments | 87.09M | ||
| Investments Current | 652.00K | ||
| Investments Non-Current | 86.44M | ||
| Trade and Non-Trade Receivables | 492.03M | ||
| Current Assets | 1.33B | ||
| Property, Plant & Equipment Net | 501.52M | ||
| Total Assets | 3.16B | ||
| Debt Current | 9.86M | ||
| Total Debt | 47.45M | ||
| Current Liabilities | 416.33M | ||
| Debt Non-Current | 37.59M | ||
| Total Liabilities | 563.89M | ||
| Accumulated Retained Earnings (Deficit) | 2.60B | ||
| Accumulated Other Comprehensive Income | -15.47M | ||
| Shareholders Equity | 2.58B | ||
| Shareholders Equity (USD) | 2.58B | ||
| Assets Non-Current | 1.83B | ||
| Total Debt (USD) | 47.45M | ||
| Deferred Revenue | 33.59M | ||
| Goodwill and Intangible Assets | 910.78M | ||
| Inventory | 30.77M | ||
| Liabilities Non-Current | 147.56M | ||
| Trade and Non-Trade Payables | 372.88M | ||
| Tax Assets | 213.17M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 25.07M | ||
| Net Cash Flow from Financing | -91.01M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 65.08M | ||
| Capital Expenditure | -19.79M | ||
| Issuance (Purchase) of Equity Shares | -56.50M | ||
| Payment of Dividends & Other Cash Distributions | -33.98M | ||
| Net Cash Flow from Investing | -9.79M | ||
| Net Cash Flow from Operations | 167.46M | ||
| Effect of Exchange Rate Changes on Cash | -1.57M | ||
| Share Based Compensation | 30.96M | ||